We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
15 hedge funds and large institutions have $1.45M invested in Decoy Therapeutics in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% less ownership
Funds ownership: 0% → 0% (-0%)
12% less funds holding
Funds holding: 17 → 15 (-2)
45% less capital invested
Capital invested by funds: $2.63M → $1.45M (-$1.18M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$15.8K |
| 2 |
VF
Virtu Financial
New York
|
+$15.8K |
Top Sellers
| 1 |
SCM
Sio Capital Management
New York
|
-$671K |
| 2 |
Renaissance Technologies
New York
|
-$47.3K |
| 3 |
Two Sigma Advisers
New York
|
-$47.3K |
| 4 |
Two Sigma Investments
New York
|
-$45K |
| 5 |
1WM
1900 Wealth Management
San Antonio,
Texas
|
-$20K |